SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001999371-24-005506
Filing Date
2024-05-01
Accepted
2024-05-01 08:45:00
Documents
7
Effectiveness Date
2024-05-01

Document Format Files

Seq Description Document Type Size
1 INITIAL REGISTRATION STATEMENT summit_s8-043024.htm S-8 62226
2 OPINION OF BAKERHOSTETLER LLP, COUNSEL TO THE REGISTRANT ex5-1.htm EX-5.1 7499
3 CONSENT OF PRICEWATERHOUSECOOPERS LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING ex23-2.htm EX-23.2 2317
4 2020 STOCK INCENTIVE PLAN (AS AMENDED AND RESTATED AS OF OCTOBER 12, 2023) ex99-1.htm EX-99.1 78586
5 CALCULATION OF FILING FEE TABLES ex107.htm EX-FILING FEES 10229
6 GRAPHIC image001.jpg GRAPHIC 4475
7 GRAPHIC image002.jpg GRAPHIC 7202
  Complete submission text file 0001999371-24-005506.txt   178474
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 650-460-8308
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279024 | Film No.: 24900233
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)